Effects of edaravone on interleukin-6 and interleukin-10 in patients undergoing one-lung ventilation
Xunjun Shuai
Abstract
Xunjun Shuai
Abstract
AIM To investigate the effects of edaravone on interleukin-6(IL-6) and interleukin-10(IL- 10) and the expression of their mRNA in patients undergoing one-lung ventilation(OLV).METHODS Twenty-four ASAⅠorⅡpatients with lung cancer,aged 48 - 67 years,undergoing elective lung resection were randomly divided into control group and edaravone group(n = 12 each).Anesthesia was induced with midazolam 0.03 mg·kg~(-1),fentanyl 3μg·kg~(-1) and 8%sevoflurane,and maintained with same combined inhaled and intravenous anesthesia.After the induction of anesthesia,the patients in the edaravone group were received edaravone 0.5mg·kg~(-1)(diluted in sodium chloride injection 100 mL),and the patients in the control group were received with the same amount of sodium chloride injection.Blood sample were taken before skin incision(T_1),60 min after lung inflation(T_2) and 1 h after surgery(T_3) for the determination of plasma IL-6 and IL-10 concentration and the expression of their mRNA.RESULTS The levels of IL-6 and IL-10 and the expression of their mRNA were higher at T_2,T_3 than those at T_1 in both groups.IL-6 level and its mRNA,IL-6/IL-10 and IL-6 mRNA/ IL-10 mRNA were all significantly lower at T_2 and T_3 in the edaravone group than those in the control group(P0.05).CONCLUSION Edaravone is effective in reducing plasma IL-6 and maintaining a relative stability of IL- 6/IL-10 in patients undergoing OLV.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM To investigate the effects of edaravone on interleukin-6(IL-6) and interleukin-10(IL- 10) and the expression of their mRNA in patients undergoing one-lung ventilation(OLV).METHODS Twenty-four ASAⅠorⅡpatients with lung cancer,aged 48 - 67 years,undergoing elective lung resection were randomly divided into control group and edaravone group(n = 12 each).Anesthesia was induced with midazolam 0.03 mg·kg~(-1),fentanyl 3μg·kg~(-1) and 8%sevoflurane,and maintained with same combined inhaled and intravenous anesthesia.After the induction of anesthesia,the patients in the edaravone group were received edaravone 0.5mg·kg~(-1)(diluted in sodium chloride injection 100 mL),and the patients in the control group were received with the same amount of sodium chloride injection.Blood sample were taken before skin incision(T_1),60 min after lung inflation(T_2) and 1 h after surgery(T_3) for the determination of plasma IL-6 and IL-10 concentration and the expression of their mRNA.RESULTS The levels of IL-6 and IL-10 and the expression of their mRNA were higher at T_2,T_3 than those at T_1 in both groups.IL-6 level and its mRNA,IL-6/IL-10 and IL-6 mRNA/ IL-10 mRNA were all significantly lower at T_2 and T_3 in the edaravone group than those in the control group(P0.05).CONCLUSION Edaravone is effective in reducing plasma IL-6 and maintaining a relative stability of IL- 6/IL-10 in patients undergoing OLV.
Key concepts: Medicine, Anesthesia, Edaravone, Midazolam, Fentanyl, Interleukin, Lung cancer, Sevoflurane